By Trinity Partners

closed 10/1/2019 via BusinessWire

Trinity, acquired Bell Canyon Consulting

synopsis: TRINITY, the global life sciences commercialization solutions provider, has acquired Bell Canyon Consulting, a data management consulting company with core expertise in master data management, data warehousing, business intelligence, and other information technology services.
buyer parent: Parthenon Capital Partners
buyer: Trinity
TRINITY is a global commercialization partner to the life sciences industry, providing evidence-based solutions throughout the product lifecycle. TRINITY is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. "
target: Bell Canyon Consulting
Bell Canyon Consulting is a data management consulting company with core expertise in master data management, data warehousing, business intelligence, and other information technology services. Bell Canyon’s mission is to enable life sciences clients to drive revenue.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/19/2013 via BusinessWire

Huron Consulting Group Inc., will acquire The Frankel Group Associates LLC

synopsis: Huron Consulting Group, a leading provider of business consulting services, announced that it has entered into an agreement to acquire the assets of The Frankel Group Associates LLC, a life sciences consulting firm. The acquisition will expand Huron’s strategy, advanced analytics, and regulatory compliance offerings to life sciences clients.
buyer: Huron Consulting Group Inc. (HURN:$726.27)
Huron Consulting Group helps clients in diverse industries improve performance, comply with complex regulations, reduce costs, recover from distress, leverage technology, and stimulate growth. The Company teams with its clients to deliver sustainable and measurable results. "
target: The Frankel Group Associates LLC
Frankel Group is a leading strategy consulting firm with offices in New York City, Cambridge, Massachusetts, and Tel Aviv, Israel that has served the life science industry and related segments since 1993.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2013 via BNC Analysis

DrugDev, acquired CFS Clinical

synopsis: DrugDev, an interactive network and data sharing platform for over 80,000 clinical trial doctors in 93 countries, announced its acquisition of CFS Clinical (CFS), the leading specialty provider focused on the business and financial management activities for clinical trials.
buyer: DrugDev
DrugDev helps the clinical trials industry run faster, cheaper and smarter trials. Experienced Investigators choose to be part of the free network to access new clinical trial opportunities they would not otherwise have learnt about. "
target: CFS Clinical
CFS Clinical (CFS) is a technology-enabled service provider focused on the business and financial management activities for clinical trials.CFS’ experts deliver best-in-class Investigator site payment and study startup solutions around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2019 via BusinessWire

Validant, acquired DataRevive LLC

synopsis: Validant, a leading transatlantic quality, compliance and regulatory consulting group, has acquired DataRevive, a regulatory strategy and consultancy firm that focuses on supporting pharma and biotech to navigate the regulatory approval pathway for global clients in the US market.
buyer parent: GHO Capital
buyer: Validant
Validant is a leading international Quality, Compliance, and Regulatory consulting firm, blending industry expertise with innovation to create custom solutions for companies on the frontier of health. "
target: DataRevive LLC
DataRevive is a leading Regulatory Affairs consulting firm, providing high quality advice and expertise from the perspective of industry and regulators to support customers from across pharma and biotech as they seek to navigate the regulatory approval process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/3/2015 via PR Newswire

Publicis Touchpoint Solutions, Inc., acquired Tardis Medical Consultancy

synopsis: Publicis Healthcare (PHCG) announced that it has acquired Tardis Medical, a highly respected clinical and medical affairs outsourcing organization and consultancy business. The agency will be aligned with Publicis Touchpoint Solutions, part of PHCG, Inc—a leading provider of customized, omnichannel healthcare sales, service, and clinical teams.
buyer parent: Publicis Groupe SA
buyer: Publicis Touchpoint Solutions, Inc.
Publicis Touchpoint Solutions designs and implements customized healthcare sales, service, and communications teams. They provide field sales and service, live video detailing, inside credentialed sales specialists, inside sales and service, clinical health educators, and medical science liaisons. "
target: Tardis Medical Consultancy
Tardis Medical is a Clinical and Medical Affairs consultancy, enabling pharmaceutical and life sciences companies to work as effectively as possible through: consultancy on strategic issues and operational matters, capabilities development, and resource augmentation of field based consultants.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/18/2012 via BusinessWire

Adjility Health will be merged with Alliance Life Sciences Consulting Group, Inc,

synopsis: Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, and Adjility Consulting, a consulting firm specializing in management consulting and analytic solutions for clinical operations and the global market access, pricing and reimbursement space, announced that the two companies will merge.
buyer: Alliance Life Sciences Consulting Group, Inc
Alliance Life Sciences Consulting Group employs more than 175 professionals who collectively understand the business challenges of the Life Sciences industry and offer solutions for Sales & Marketing, Managed Care & Government Contracting, Commercial Operations, Information Management and Analytics."
target: Adjility Health
Adjility Health is dedicated to helping healthcare companies improve their operations through the use of strategic consulting services and very industry domain-specific analytic, forecasting, predictive trending and other data insight tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via Company Press Release

Advarra, acquired Kinetiq

synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent: Linden Capital Partners
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/21/2018 via BusinessWire

GHO Capital, acquired Validant

synopsis: GHO Capital, the European specialist investor in healthcare, has acquired a majority stake in Validant. Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
buyer: GHO Capital
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. They apply global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market leading businesses of strategic global value."
target: Validant
Operating globally with offices in Europe and North America, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2018 via PR Newswire

Premier Research Group, acquired Regulatory Professionals, Inc.

synopsis: Premier Research, a global provider of clinical development services to biopharmaceutical product innovators, has acquired Regulatory Professionals, Inc. (RPI), a California-based company that provides regulatory expertise and solutions to biotechnology, pharmaceutical, and medical device companies.
buyer parent: ECI Partners
buyer: Premier Research Group
Premier Research is a leading clinical development service provider that helps biotech and specialty pharma innovators — small companies with big ambitions — transform life-changing ideas into new medicines. "
target: Regulatory Professionals, Inc.
Regulatory Professionals, Inc. (RPI) provides strategic advice, regulatory planning, and a full range of submission services, helping its clients advance the development and registration of their products in worldwide markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2018 via Company Press Release

Bertram Capital Management LLC, acquired Registrar Corp

synopsis: Bertram Capital announced its investment in Registrar, LLC, a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
buyer: Bertram Capital Management LLC
Bertram Capital is a private equity firm targeting investments in lower middle market companies. By supplying flexible investment capital and committing a wealth of operational and strategic resources, they make their core objective to move companies toward unlocking their full potential. "
target: Registrar Corp
Registrar Corp is a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via Company Press Release

Linden Capital Partners, acquired ProPharma Group

synopsis: Linden Capital Partners, a Chicago-based healthcare private equity firm, announced that it has completed its acquisition of ProPharma Group. ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
buyer: Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. "
target: ProPharma Group
ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/27/2013 via Company Press Release

Cumberland, purchased Life Sciences Consulting Division from Mindlance

synopsis: Cumberland Consulting Group LLC, has purchased the Mindlance Life Sciences Consulting division of Mindlance Inc., a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
buyer parent: Tailwind Capital Partners
buyer: Cumberland
Cumberland Consulting provides healthcare IT consulting services, including, Planning & Assessment; Workflow Management; Vendor Selection; Software Implementation; and Project Management to healthcare organizations. "
seller: Mindlance
Mindlance Inc., is a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2012 via BusinessWire

Dohmen Company, acquired BioSoteria, Inc.

synopsis: The Dohmen Company has acquired BioSoteria, a leading provider of drug safety and risk management services to the biopharmaceutical industry. The BioSoteria management team has experience building drug safety departments from the ground up at start-up companies and expanding pharmacovigilance capabilities for larger companies.
buyer: Dohmen Company
Dohmen is a provider of outsourced business services. Dohmen’s portfolio of service offerings includes outsourced business services to life science manufacturers through DDN, and benefit management services to life science payers through RESTAT. "
target: BioSoteria, Inc.
BioSoteria provides a broad range of drug safety services to the biopharmaceutical industry. BioSoteria helps companies manage the safety of their products with a regulatory-compliant, best-practices approach. Being a trusted pharmacovigilance service provider begins with leadership.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/11/2019 via PR Newswire

Indegene Lifesystems Pvt Ltd., acquired DT Associates

synopsis: Indegene, a global next-generation solutions company in the Life Sciences industry, has acquired London-based DT Associates, a consulting company focused on helping pharmaceutical companies achieve excellence in Customer Experience and Digital Operations. DT Associates will operate as a separate entity in Indegene Private Ltd, as DT Consulting.
buyer: Indegene Lifesystems Pvt Ltd.
Indegene enables global health care companies to address complex challenges and drive better health and business outcomes by integrating analytics, technology, operations, and medical expertise. Indegene drives innovation by combining medical expertise with contemporary digital and AI technologies. "
target: DT Associates
London-based DT Associates helps pharmaceutical firms achieve digital excellence to create successful customer experiences. DT uses fact-based insights from curated research, assessments, benchmarks, consulting projects, and more to address digital transformation in the pharmaceutical industry.
price ($mm)
$12
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via Company Press Release

UDG Healthcare plc, acquired Putnam Associates

synopsis: UDG Healthcare plc, a leading international healthcare services provider, announces the acquisition of Putnam Associates, a company that provides strategic advice based on sophisticated and robust analytics to biopharmaceutical, diagnostics, and medical device clients.
buyer: UDG Healthcare plc (LSE:UDG:$1,296.52)
UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Putnam Associates
Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/7/2018 via BNC Analysis

Ancor Capital Partners, acquired STATinMed

synopsis: Ancor Capital Partners, a Dallas-based private equity firm, announces the acquisition of STATinMED Research, a leading medical technology company in the health economics and outcomes research industry. STATinMED provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies.
buyer: Ancor Capital Partners
Ancor Capital Partners is an operations-oriented private equity firm focused on lower middle-market companies with EBITDA of $5-$15 million. Extensive operational experience gives the Ancor team a unique understanding of the critical business issues faced by lower middle-market companies. "
target: STATinMed
STATinMED Research provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies. All STATinMED Research consultants hold academic positions with prestigious universities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2012 via BusinessWire

IMS Health Incorporated, acquired TTC LLC

synopsis: IMS Health has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical trials. TTC offers clients a robust set of clinical trial cost benchmarks, budgeting and negotiation tools.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: TTC LLC
TTC is the leader in global clinical trial cost benchmarking. With offices in Philadelphia, TTC has a proven track record in all aspects of outsourcing cost management, from the budgeting of protocols and clinical trials to negotiations with clinical sites and other providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/6/2017 via Company Press Release

The Access Group, acquired Alliance Life Sciences

synopsis: Water Street Healthcare Partners, through its subsidiary, The Access Group, has acquired Alliance Life Sciences. Alliance specializes in maximizing revenue and optimizing pricing for its customers. The firm offers global pricing analytic tools and data, outsourced contract and revenue management services and digital marketing operational services.
buyer parent: Water Street Healthcare Partners
buyer: The Access Group
The Access Group offers a breadth of services to clients, from traditional “block-and-tackle” launch execution tactics to in-depth market assessments. The company is dedicated to complete product life cycle management, creating brand solutions that drive demand across multiple stakeholder channels. "
target: Alliance Life Sciences
Alliance Life Sciences is a global innovator that delivers peace of mind and unlocks business value with unique solutions to complex commercial problems. Its worldwide team of experts provides insights and solves problems in contracting, pricing, reimbursement, and commercial operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/19/2013 via BusinessWire

Huron Consulting Group Inc., will acquire The Frankel Group Associates LLC

synopsis: Huron Consulting Group, a leading provider of business consulting services, announced that it has entered into an agreement to acquire the assets of The Frankel Group Associates LLC, a life sciences consulting firm. The acquisition will expand Huron’s strategy, advanced analytics, and regulatory compliance offerings to life sciences clients.
buyer: Huron Consulting Group Inc. (HURN:$726.27)
Huron Consulting Group helps clients in diverse industries improve performance, comply with complex regulations, reduce costs, recover from distress, leverage technology, and stimulate growth. The Company teams with its clients to deliver sustainable and measurable results. "
target: The Frankel Group Associates LLC
Frankel Group is a leading strategy consulting firm with offices in New York City, Cambridge, Massachusetts, and Tel Aviv, Israel that has served the life science industry and related segments since 1993.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2013 via BNC Analysis

DrugDev, acquired CFS Clinical

synopsis: DrugDev, an interactive network and data sharing platform for over 80,000 clinical trial doctors in 93 countries, announced its acquisition of CFS Clinical (CFS), the leading specialty provider focused on the business and financial management activities for clinical trials.
buyer: DrugDev
DrugDev helps the clinical trials industry run faster, cheaper and smarter trials. Experienced Investigators choose to be part of the free network to access new clinical trial opportunities they would not otherwise have learnt about. "
target: CFS Clinical
CFS Clinical (CFS) is a technology-enabled service provider focused on the business and financial management activities for clinical trials.CFS’ experts deliver best-in-class Investigator site payment and study startup solutions around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2019 via BusinessWire

Validant, acquired DataRevive LLC

synopsis: Validant, a leading transatlantic quality, compliance and regulatory consulting group, has acquired DataRevive, a regulatory strategy and consultancy firm that focuses on supporting pharma and biotech to navigate the regulatory approval pathway for global clients in the US market.
buyer parent: GHO Capital
buyer: Validant
Validant is a leading international Quality, Compliance, and Regulatory consulting firm, blending industry expertise with innovation to create custom solutions for companies on the frontier of health. "
target: DataRevive LLC
DataRevive is a leading Regulatory Affairs consulting firm, providing high quality advice and expertise from the perspective of industry and regulators to support customers from across pharma and biotech as they seek to navigate the regulatory approval process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/3/2015 via PR Newswire

Publicis Touchpoint Solutions, Inc., acquired Tardis Medical Consultancy

synopsis: Publicis Healthcare (PHCG) announced that it has acquired Tardis Medical, a highly respected clinical and medical affairs outsourcing organization and consultancy business. The agency will be aligned with Publicis Touchpoint Solutions, part of PHCG, Inc—a leading provider of customized, omnichannel healthcare sales, service, and clinical teams.
buyer parent: Publicis Groupe SA
buyer: Publicis Touchpoint Solutions, Inc.
Publicis Touchpoint Solutions designs and implements customized healthcare sales, service, and communications teams. They provide field sales and service, live video detailing, inside credentialed sales specialists, inside sales and service, clinical health educators, and medical science liaisons. "
target: Tardis Medical Consultancy
Tardis Medical is a Clinical and Medical Affairs consultancy, enabling pharmaceutical and life sciences companies to work as effectively as possible through: consultancy on strategic issues and operational matters, capabilities development, and resource augmentation of field based consultants.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/18/2012 via BusinessWire

Adjility Health will be merged with Alliance Life Sciences Consulting Group, Inc,

synopsis: Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, and Adjility Consulting, a consulting firm specializing in management consulting and analytic solutions for clinical operations and the global market access, pricing and reimbursement space, announced that the two companies will merge.
buyer: Alliance Life Sciences Consulting Group, Inc
Alliance Life Sciences Consulting Group employs more than 175 professionals who collectively understand the business challenges of the Life Sciences industry and offer solutions for Sales & Marketing, Managed Care & Government Contracting, Commercial Operations, Information Management and Analytics."
target: Adjility Health
Adjility Health is dedicated to helping healthcare companies improve their operations through the use of strategic consulting services and very industry domain-specific analytic, forecasting, predictive trending and other data insight tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via Company Press Release

Advarra, acquired Kinetiq

synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent: Linden Capital Partners
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/21/2018 via BusinessWire

GHO Capital, acquired Validant

synopsis: GHO Capital, the European specialist investor in healthcare, has acquired a majority stake in Validant. Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
buyer: GHO Capital
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. They apply global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market leading businesses of strategic global value."
target: Validant
Operating globally with offices in Europe and North America, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2018 via PR Newswire

Premier Research Group, acquired Regulatory Professionals, Inc.

synopsis: Premier Research, a global provider of clinical development services to biopharmaceutical product innovators, has acquired Regulatory Professionals, Inc. (RPI), a California-based company that provides regulatory expertise and solutions to biotechnology, pharmaceutical, and medical device companies.
buyer parent: ECI Partners
buyer: Premier Research Group
Premier Research is a leading clinical development service provider that helps biotech and specialty pharma innovators — small companies with big ambitions — transform life-changing ideas into new medicines. "
target: Regulatory Professionals, Inc.
Regulatory Professionals, Inc. (RPI) provides strategic advice, regulatory planning, and a full range of submission services, helping its clients advance the development and registration of their products in worldwide markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2018 via Company Press Release

Bertram Capital Management LLC, acquired Registrar Corp

synopsis: Bertram Capital announced its investment in Registrar, LLC, a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
buyer: Bertram Capital Management LLC
Bertram Capital is a private equity firm targeting investments in lower middle market companies. By supplying flexible investment capital and committing a wealth of operational and strategic resources, they make their core objective to move companies toward unlocking their full potential. "
target: Registrar Corp
Registrar Corp is a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via Company Press Release

Linden Capital Partners, acquired ProPharma Group

synopsis: Linden Capital Partners, a Chicago-based healthcare private equity firm, announced that it has completed its acquisition of ProPharma Group. ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
buyer: Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. "
target: ProPharma Group
ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/27/2013 via Company Press Release

Cumberland, purchased Life Sciences Consulting Division from Mindlance

synopsis: Cumberland Consulting Group LLC, has purchased the Mindlance Life Sciences Consulting division of Mindlance Inc., a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
buyer parent: Tailwind Capital Partners
buyer: Cumberland
Cumberland Consulting provides healthcare IT consulting services, including, Planning & Assessment; Workflow Management; Vendor Selection; Software Implementation; and Project Management to healthcare organizations. "
seller: Mindlance
Mindlance Inc., is a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2012 via BusinessWire

Dohmen Company, acquired BioSoteria, Inc.

synopsis: The Dohmen Company has acquired BioSoteria, a leading provider of drug safety and risk management services to the biopharmaceutical industry. The BioSoteria management team has experience building drug safety departments from the ground up at start-up companies and expanding pharmacovigilance capabilities for larger companies.
buyer: Dohmen Company
Dohmen is a provider of outsourced business services. Dohmen’s portfolio of service offerings includes outsourced business services to life science manufacturers through DDN, and benefit management services to life science payers through RESTAT. "
target: BioSoteria, Inc.
BioSoteria provides a broad range of drug safety services to the biopharmaceutical industry. BioSoteria helps companies manage the safety of their products with a regulatory-compliant, best-practices approach. Being a trusted pharmacovigilance service provider begins with leadership.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/11/2019 via PR Newswire

Indegene Lifesystems Pvt Ltd., acquired DT Associates

synopsis: Indegene, a global next-generation solutions company in the Life Sciences industry, has acquired London-based DT Associates, a consulting company focused on helping pharmaceutical companies achieve excellence in Customer Experience and Digital Operations. DT Associates will operate as a separate entity in Indegene Private Ltd, as DT Consulting.
buyer: Indegene Lifesystems Pvt Ltd.
Indegene enables global health care companies to address complex challenges and drive better health and business outcomes by integrating analytics, technology, operations, and medical expertise. Indegene drives innovation by combining medical expertise with contemporary digital and AI technologies. "
target: DT Associates
London-based DT Associates helps pharmaceutical firms achieve digital excellence to create successful customer experiences. DT uses fact-based insights from curated research, assessments, benchmarks, consulting projects, and more to address digital transformation in the pharmaceutical industry.
price ($mm)
$12
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via Company Press Release

UDG Healthcare plc, acquired Putnam Associates

synopsis: UDG Healthcare plc, a leading international healthcare services provider, announces the acquisition of Putnam Associates, a company that provides strategic advice based on sophisticated and robust analytics to biopharmaceutical, diagnostics, and medical device clients.
buyer: UDG Healthcare plc (LSE:UDG:$1,296.52)
UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Putnam Associates
Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/7/2018 via BNC Analysis

Ancor Capital Partners, acquired STATinMed

synopsis: Ancor Capital Partners, a Dallas-based private equity firm, announces the acquisition of STATinMED Research, a leading medical technology company in the health economics and outcomes research industry. STATinMED provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies.
buyer: Ancor Capital Partners
Ancor Capital Partners is an operations-oriented private equity firm focused on lower middle-market companies with EBITDA of $5-$15 million. Extensive operational experience gives the Ancor team a unique understanding of the critical business issues faced by lower middle-market companies. "
target: STATinMed
STATinMED Research provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies. All STATinMED Research consultants hold academic positions with prestigious universities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2012 via BusinessWire

IMS Health Incorporated, acquired TTC LLC

synopsis: IMS Health has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical trials. TTC offers clients a robust set of clinical trial cost benchmarks, budgeting and negotiation tools.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: TTC LLC
TTC is the leader in global clinical trial cost benchmarking. With offices in Philadelphia, TTC has a proven track record in all aspects of outsourcing cost management, from the budgeting of protocols and clinical trials to negotiations with clinical sites and other providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/6/2017 via Company Press Release

The Access Group, acquired Alliance Life Sciences

synopsis: Water Street Healthcare Partners, through its subsidiary, The Access Group, has acquired Alliance Life Sciences. Alliance specializes in maximizing revenue and optimizing pricing for its customers. The firm offers global pricing analytic tools and data, outsourced contract and revenue management services and digital marketing operational services.
buyer parent: Water Street Healthcare Partners
buyer: The Access Group
The Access Group offers a breadth of services to clients, from traditional “block-and-tackle” launch execution tactics to in-depth market assessments. The company is dedicated to complete product life cycle management, creating brand solutions that drive demand across multiple stakeholder channels. "
target: Alliance Life Sciences
Alliance Life Sciences is a global innovator that delivers peace of mind and unlocks business value with unique solutions to complex commercial problems. Its worldwide team of experts provides insights and solves problems in contracting, pricing, reimbursement, and commercial operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

By Trinity Partners


read more

Bell Canyon Consulting

TGaS Advisors, LLC

read more

The Frankel Group Associates LLC

CFS Clinical

DataRevive LLC

TGaS Advisors, LLC

Tardis Medical Consultancy

Adjility Health

Kinetiq

Validant

Regulatory Professionals, Inc.

Registrar Corp

ProPharma Group

Mindlance

BioSoteria, Inc.

DT Associates

Putnam Associates

Tri Stat

STATinMed

Abacus International

TTC LLC

Alliance Life Sciences

read more

The Frankel Group Associates LLC

CFS Clinical

DataRevive LLC

TGaS Advisors, LLC

Tardis Medical Consultancy

Adjility Health

Kinetiq

Validant

Regulatory Professionals, Inc.

Registrar Corp

ProPharma Group

Mindlance

BioSoteria, Inc.

DT Associates

Putnam Associates

Tri Stat

STATinMed

Abacus International

TTC LLC

Alliance Life Sciences

Geography
Matching Companies
Ticker: PBSV
 
 
 
 
 
 
 
 
Pharma-Bio Serv Inc.
PharmaBio Serv offers a full range of Regulatory Compliance Quality Systems, Validation & Qualification Services and Technology Transfer based on the latest FDA guidelines, as well as day to day process support.
year
2008
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,296.52
EBITDA ($mm)
$167.22
EBIT ($mm)
$114.30
Net Income ($mm)
$25.89
Employees
9000
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: NCI
 
 
 
 
 
 
 
 
Navigant Consulting
Navigant Consulting
Navigant is a consultancy that serves a variety of industries, including healthcare. Navigant’s current service lines includes revenue cycle management services that help healthcare providers assess and optimize their electronic health records and other IT systems.
year
2019
rev ($mm)
$728.72
EBITDA ($mm)
$70.78
EBIT ($mm)
$46.02
Net Income ($mm)
$93.32
Employees
6175
  • drill down
  • watch
Ticker: OTCPK:MDCL
 
 
 
 
 
 
 
 
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc. was established in March 2014. They have provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state.
year
2016
rev ($mm)
$0.82
EBITDA ($mm)
($0.18)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
4
  • drill down
  • watch
Ticker: PBSV
 
 
 
 
 
 
 
 
Pharma-Bio Serv Inc.
PharmaBio Serv offers a full range of Regulatory Compliance Quality Systems, Validation & Qualification Services and Technology Transfer based on the latest FDA guidelines, as well as day to day process support.
year
2008
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,296.52
EBITDA ($mm)
$167.22
EBIT ($mm)
$114.30
Net Income ($mm)
$25.89
Employees
9000
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: NCI
 
 
 
 
 
 
 
 
Navigant Consulting
Navigant Consulting
Navigant is a consultancy that serves a variety of industries, including healthcare. Navigant’s current service lines includes revenue cycle management services that help healthcare providers assess and optimize their electronic health records and other IT systems.
year
2019
rev ($mm)
$728.72
EBITDA ($mm)
$70.78
EBIT ($mm)
$46.02
Net Income ($mm)
$93.32
Employees
6175
  • drill down
  • watch
Ticker: OTCPK:MDCL
 
 
 
 
 
 
 
 
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc. was established in March 2014. They have provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state.
year
2016
rev ($mm)
$0.82
EBITDA ($mm)
($0.18)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
4
  • drill down
  • watch